Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells. 1993

B P Hughes, and T F Booth, and A S Belyaev, and D McIlroy, and J Jowett, and P Roy
Laboratory of Molecular Biophysics, University of Oxford, United Kingdom.

To determine the interaction between the gag precursor and the viral protease and to confirm the role of gag precursor in formation of human immunodeficiency virus type 1 particles, the gag and protease encoding regions of a proviral genome with mutations at the site between p17 and p24 or p24 and p15 were expressed by recombinant baculoviruses under the transcriptional control of the strong polyhedrin promoter. Western blot analyses of the expressed products of p17-p24 mutated viruses revealed that both 41- and 55-kDa proteins were synthesized. However, free p24, p17, and the other smaller cleavage products (p9, p6) could not be detected in infected insect cells. The second recombinant virus (p24-p15) synthesized not only a 55k-Da protein, but also a number of smaller products including a 40k-Da protein, p24, and p17. Examination of the insect cells infected by either of these two recombinant viruses by electron microscopy failed to detect any gag particle formation, although some irregular membrane protrusions and profound distortions of the cell surface were clearly visible in the cells infected with recombinant mutant p17-p24 virus, but not with recombinant p24-p15 mutants. To investigate the morphogenic capability of the gag-pol fusion protein, a mutant gag-pol gene containing an inactive protease as well as a modified gag-pol gene lacking the frameshifting activity were expressed in insect cells. While the inactive protease mutant was capable of forming immature particles that were secreted, the frameshifting mutant synthesized only an aberrant form of gag particles with a large radius of curvature in lieu of spherical particles. However, when this mutant was expressed in insect cells in the presence of a truncated gag protein with M(r) of 46 kDa (lacking only the p6 domain), normal immature particles containing both antigens were formed.

UI MeSH Term Description Entries
D007915 Lepidoptera A large order of insects comprising the butterflies and moths.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009024 Morphogenesis The development of anatomical structures to create the form of a single- or multi-cell organism. Morphogenesis provides form changes of a part, parts, or the whole organism.
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015683 Gene Products, gag Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen. Viral gag Proteins,gag Antigen,gag Gene Product,gag Gene Products,gag Polyproteins,gag Protein,gag Viral Proteins,Gene Product, gag,Retroviral Antigen gag Protein,gag Antigens,gag Gene Related Protein,gag Polyprotein,Antigen, gag,Antigens, gag,Polyprotein, gag,Polyproteins, gag,Protein, gag,Proteins, Viral gag,Proteins, gag Viral,Viral Proteins, gag,gag Proteins, Viral
D015685 Fusion Proteins, gag-pol Polyprotein products of a fused portion of retroviral mRNA containing the gag and pol genes. The polyprotein is synthesized only five percent of the time since pol is out of frame with gag, and is generated by ribosomal frameshifting. gag-pol Fusion Proteins,gag-pol Protein,gag-pol Fused Protein,Fused Protein, gag-pol,Fusion Proteins, gag pol,Protein, gag-pol,Protein, gag-pol Fused,Proteins, gag-pol Fusion,gag pol Fused Protein,gag pol Fusion Proteins,gag pol Protein

Related Publications

B P Hughes, and T F Booth, and A S Belyaev, and D McIlroy, and J Jowett, and P Roy
January 2004, Journal of virology,
B P Hughes, and T F Booth, and A S Belyaev, and D McIlroy, and J Jowett, and P Roy
April 2011, Journal of virology,
B P Hughes, and T F Booth, and A S Belyaev, and D McIlroy, and J Jowett, and P Roy
May 1991, Journal of virology,
B P Hughes, and T F Booth, and A S Belyaev, and D McIlroy, and J Jowett, and P Roy
June 1991, Journal of virology,
B P Hughes, and T F Booth, and A S Belyaev, and D McIlroy, and J Jowett, and P Roy
July 1993, Journal of virology,
B P Hughes, and T F Booth, and A S Belyaev, and D McIlroy, and J Jowett, and P Roy
July 1999, The Journal of biological chemistry,
B P Hughes, and T F Booth, and A S Belyaev, and D McIlroy, and J Jowett, and P Roy
December 1996, Journal of virology,
B P Hughes, and T F Booth, and A S Belyaev, and D McIlroy, and J Jowett, and P Roy
October 2003, Journal of virology,
B P Hughes, and T F Booth, and A S Belyaev, and D McIlroy, and J Jowett, and P Roy
July 1997, Journal of virology,
Copied contents to your clipboard!